Prepaid Expenses and Other Current Assets (Details) - USD ($) |
Mar. 31, 2021 |
Dec. 31, 2020 |
|---|---|---|
| Prepaid Expenses and Other Current Assets | ||
| Prepaid Insurance | $ 1,206,366 | $ 1,586,042 |
| Prepaid clinical research costs | 2,178,854 | 85,270 |
| Prepaid investigator meeting expenses | 253,582 | |
| Prepaid services | 50,175 | 5,729 |
| Miscellaneous receivables | 324 | |
| Total prepaid expenses and other assets | $ 3,688,977 | $ 1,677,365 |
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Represents element information pertaining to miscellaneous receivables. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration paid in advance for clinical research costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration paid in advance for investigator meeting expenses that provide economic benefits within a future period of one year or the normal operating cycle, if longer. No definition available.
|
| X | ||||||||||
- Definition Represents element information pertaining to prepaid services. No definition available.
|